USPTO serial 77551150
COMPETITIVE HEALTH ANALYTICS
Reviewed by CopyMark Law Group
Reg. 4202615Status 710
- Filing date
- Status date
- Registration date
- Sep 4, 2012
- Examiner
- HENRY, NAKIA D
- Law office
- TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with COMPETITIVE HEALTH ANALYTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Louisville, KY
Louisville, KY
Louisville, KY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth T. Veirs
500 West Main Street, 21st FloorLouisville, KY 40202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | consulting services related to medical cost management; management services of a business nature for clinical trials in the field of investigational drugs; data compilation and analysis in the field of healthcare management, namely, conducting pharmacoeconomics, health economics and statistical research for business purposes; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business consulting services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; supply chain management, namely, tracking and management of clinical trial supplies and research materials used in such; providing statistical information and analysis via computer for use with clinical trial data for business purposes; business consultation services for the healthcare industry; business consulting in the field of clinical and health economic research services for healthcare companies; preparing statistical business reports resulting from clinical trials and laboratory data analysis; consultation in the field of patient recruitment; data preparation for business purposes, namely, preparation of medical and scientific data for use by insurance companies and third party medical reimbursement organizations | SECTION 8 - CANCELLED | — |
| 042 | medical and scientific research, data collection and analysis in the nature of clinical research and conducting clinical trials in the fields of healthcare, medical care and pharmaceuticals; scientific research in the field of general health and medical and scientific research, namely, conducting clinical trials by providing clinical indicators calculated using medical claims data that are used to measure quality of medical care; compilation and analysis in the field of scientific and medical research, namely, conducting pharmacoeconomics, health economics, medical laboratory data analysis, and statistical medical research; pharmaceutical development services in the fields of molecular medicine; healthcare, namely, scientific research consulting for improved clinical trial design; medical research that analyzes data to identify patterns across patient groups or disease progression; pharmaceutical development, namely, design, research and development of drugs, pharmaceuticals and medicines for others; clinical development services for others, namely, research and consultation in the fields of pharmaceutical drug development and clinical trial design; medical laboratory data analysis, clinical diagnosis research and diagnostic testing research; preparation of reports and research concerning development of medicines, pharmaceuticals, genetics, biology, biotechnology and pharmaceutical drugs; consulting services in the fields of pharmaceuticals research, and biotechnology fields; providing an on-line database in the field of medical, pharmaceutical, and biotechnical research and analysis; management services of a scientific and technical nature for clinical trials in the field of investigational drugs, namely, conducting clinical protocols and trials for others; consulting services regarding scientific aspects of clinical trials of investigational drugs, namely, advising others on conducting clinical protocols and trials; technical writing for others of clinical trial reports; research and consultation in the clinical medical field, namely, research and analysis provided to healthcare providers, suppliers of medical devices and pharmaceutical products, and suppliers of medical software and medical information management services; medical quality evaluation services, namely, providing data collection, analysis, and reporting services for patient data, clinical information, treatment options and treatment success for the medical industry; providing an on-line computer database in the field of healthcare, namely, health and productivity research and analysis; assessment surveys for health and medical purposes, namely, in research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; quality evaluation services, namely, surveying patients to assess quality of life, burden of disease and overall satisfaction with access to medical care to determine service quality for the medical industry | SECTION 8 - CANCELLED | — |
| 044 | consultation in the field of drug use testing services; consultation in the field of healthcare; providing pharmaceutical advice; providing an interactive on-line computer database in the field of medical diagnostics | SECTION 8 - CANCELLED | — |
| 045 | consulting services in the field of research and analysis of drug prescription and associated data, namely, regulatory compliance consulting as it applies to prescription drug sampling | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Humana Inc.
- Other trademarks owned by Humana Inc.
- Other trademarks owned by Humana Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named COMPETITIVE HEALTH ANALYTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 5, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 4, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 4, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 1, 2012 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 31, 2012 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jul 31, 2012 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 22, 2012 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 14, 2012 | IUAF | USE AMENDMENT FILED | — |
| Jun 14, 2012 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 20, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 19, 2012 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 17, 2012 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 17, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 22, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 21, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 20, 2011 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 15, 2011 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 15, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 14, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 24, 2011 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 22, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 22, 2011 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 18, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 23, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 23, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 21, 2010 | ALIE | ASSIGNED TO LIE | — |
| Oct 20, 2010 | ALIE | ASSIGNED TO LIE | — |
| Oct 13, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 13, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 13, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 13, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 21, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2010 | ALIE | ASSIGNED TO LIE | — |
| Aug 5, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 5, 2010 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 5, 2010 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 5, 2010 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 9, 2010 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 9, 2010 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 9, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 6, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 6, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2008 | NWAP | NEW APPLICATION ENTERED | — |